TP-0542354

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameTP-0542354
Drug Alias NameTP 0542354TP-0542354
ClassificationSmall molecules
Mechanisms of ActionBifunctional enzyme LpxC/FabZ inhibitors
TargetsNot applicable
Therapy Area/IndicationsGram-Negative Bacterial Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesTaisho Pharmaceutical Co LtdVernalis Plc
China Registration ClassN/A

Develop Information

Active CompaniesVernalis PlcTaisho Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsGram-Negative Bacterial Infections
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A